Table 2 Comparisons of the percentages of CD3 + , CD4 + , CD8 + , and CD19 + lymphocytes in the death and survival groups and the long-term survival group (LTSG) and mid-term survival group (MTSG) using a mixed model
From: Biomarkers of early sepsis may be correlated with outcome
Survival Group versus Death Group | LTSG versus MTSG | ||||||||
|---|---|---|---|---|---|---|---|---|---|
Variable | Model-Based | Test | p | Variable | Model-Based | Test | p | ||
Estimated Mean*(SE) | Estimated Mean*(SE) | ||||||||
CD3+ T | 0.08 | 0.79 | CD3+ T | 0.55 | 0.47 | ||||
Survival | 1.72 (0.04) | LTSG | 1.74 (0.04) | ||||||
Death | 1.76 (0.06) | MTSG | 1.70 (0.05) | ||||||
CD4+ T | 0.24 | 0.63 | CD4+ T | 0.01 | 0.93 | ||||
Survival | 1.43 (0.05) | LTSG | 1.44 (0.06) | ||||||
Death | 1.48 (0.09) | MTSG | 1.45 (0.07) | ||||||
CD8+ T | 0.36 | 0.55 | CD8+ T | 0.05 | 0.83 | ||||
Survival | 1.34 (0.06) | LTSG | 1.34 (0.05) | ||||||
Death | 1.27 (0.09) | MTSG | 1.36 (0.07) | ||||||
CD19+ B cell | 3.63 | 0.07 | CD19+ B cell | 0.14 | 0.71 | ||||
Survival | 1.17 (0.12) | LTSG | 1.15 (0.07) | ||||||
Death | 0.67 (0.24) | MTSG | 1.18 (0.08) | ||||||